First Tracks Biotherapeutics, Inc. (TRAX)
38.96
+0.50
(+1.29%)
USD |
NASDAQ |
Sep 16, 15:46
First Tracks Biotherapeutics Market Cap : 1.379B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 1.361B |
| September 14, 2026 | 1.330B |
| September 11, 2026 | 1.290B |
| September 10, 2026 | 1.344B |
| September 09, 2026 | 1.400B |
| September 08, 2026 | 1.479B |
| September 04, 2026 | 1.432B |
| September 03, 2026 | 1.504B |
| September 02, 2026 | 1.602B |
| September 01, 2026 | 1.457B |
| August 31, 2026 | 1.481B |
| August 28, 2026 | 1.481B |
| August 27, 2026 | 1.583B |
| August 26, 2026 | 1.564B |
| August 25, 2026 | 1.596B |
| August 24, 2026 | 1.532B |
| August 21, 2026 | 1.526B |
| August 20, 2026 | 1.483B |
| August 19, 2026 | 1.610B |
| August 18, 2026 | 1.553B |
| August 17, 2026 | |
| August 14, 2026 | |
| August 13, 2026 | |
| August 12, 2026 | |
| August 11, 2026 |
| Date | Value |
|---|---|
| August 10, 2026 | |
| August 07, 2026 | |
| August 06, 2026 | |
| August 05, 2026 | |
| August 04, 2026 | |
| August 03, 2026 | |
| July 31, 2026 | |
| July 30, 2026 | |
| July 29, 2026 | |
| July 28, 2026 | |
| July 27, 2026 | |
| July 24, 2026 | |
| July 23, 2026 | |
| July 22, 2026 | |
| July 21, 2026 | |
| July 20, 2026 | |
| July 17, 2026 | |
| July 16, 2026 | |
| July 15, 2026 | |
| July 14, 2026 | |
| July 13, 2026 | |
| July 10, 2026 | |
| July 09, 2026 | |
| July 08, 2026 | |
| July 07, 2026 |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Forte Biosciences, Inc. | 1.577B |
| Immunovant, Inc. | 7.483B |
| ACADIA Pharmaceuticals, Inc. | 4.732B |
| Agenus, Inc. | 306.83M |
| Alnylam Pharmaceuticals, Inc. | 32.03B |
Market Cap Related Metrics
| Price to Book Value | 8.170 |
| Price | 38.96 |
| Earnings Yield | -12.68% |